tirzepatide vs semaglutide effectiveness and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States tirzepatide vs semaglutide differences efficacy

The GLP-1R agonist liraglutide has also received regulatory approval for the treatment of obesity and conferred protection in an obesity-associated animal model of cardiomyopathy (12)

The hypothalamus responds to hormonal changes

To induce obesity, male offspring rats received subcutaneous injections of MSG [4 mg/kg body weight (bw)

Persistent hunger despite optimised dosing and lifestyle measures warrants clinical review to consider alternative GLP-1 agonists, other pharmacotherapy, specialist weight management services, or bariatric surgery

In late June, 21 plaintiffs requested that their lawsuits be combined via a process called multicounty litigation